XNASASTH
Market cap1.32bUSD
Jan 10, Last price
29.48USD
1D
-6.89%
1Q
-47.57%
Jan 2017
293.07%
Name
Apollo Medical Holdings Inc
Chart & Performance
P/E
29.26
P/S
1.16
EPS
1.01
Div Yield, %
1.06%
Shrs. gr., 5y
7.14%
Rev. gr., 5y
26.15%
Revenues
1.14b
+47.84%
Net income
45m
-34.46%
CFO
82m
+16.77%
Earnings
Feb 25, 2025
Profile
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2017‑03 | 2016‑03 | 2015‑03 | |
| Income | |||||||||
Revenues | 1,144,163 47.84% | ||||||||
Cost of revenue | 1,022,355 | ||||||||
Unusual Expense (Income) | |||||||||
NOPBT | 121,808 | ||||||||
NOPBT Margin | 10.65% | ||||||||
Operating Taxes | 40,875 | ||||||||
Tax Rate | 33.56% | ||||||||
NOPAT | 80,933 | ||||||||
Net income | 45,171 -34.46% | ||||||||
Dividends | (14,030) | ||||||||
Dividend yield | 1.04% | ||||||||
Proceeds from repurchase of equity | 2,981 | ||||||||
BB yield | -0.22% | ||||||||
| Debt | |||||||||
Debt current | 4,785 | ||||||||
Long-term debt | 249,935 | ||||||||
Deferred revenue | |||||||||
Other long-term liabilities | 20,260 | ||||||||
Net debt | (80,069) | ||||||||
| Cash flow | |||||||||
Cash from operating activities | 82,128 | ||||||||
CAPEX | (22,940) | ||||||||
Cash from investing activities | (7,113) | ||||||||
Cash from financing activities | (20,085) | ||||||||
FCF | 27,702 | ||||||||
| Balance | |||||||||
Cash | 293,594 | ||||||||
Long term investments | 41,195 | ||||||||
Excess cash | 277,581 | ||||||||
Stockholders' equity | 198,450 | ||||||||
Invested Capital | 605,442 | ||||||||
ROIC | 14.30% | ||||||||
ROCE | 14.89% | ||||||||
| EV | |||||||||
Common stock shares outstanding | 45,602 | ||||||||
Price | 29.59 -59.73% | ||||||||
Market cap | 1,349,375 -58.10% | ||||||||
EV | 1,285,292 | ||||||||
EBITDA | 139,351 | ||||||||
EV/EBITDA | 9.22 | ||||||||
Interest | 7,920 | ||||||||
Interest/NOPBT | 6.50% | ||||||||